The Trump administration has cited Dr. Andrea Baccarelli’s expertise to warn against using acetaminophen — the active ingredient in Tylenol — in pregnancy, based on an unproven autism link.
The agency revived an old treatment for cancer patients, unilaterally approving it for a subset of people with autism. Experts worry that the narrower scope will get lost in the hype.
The president delivered impassioned — if scientifically dubious — remarks about what he described as one of “the most alarming public health developments in history.”
Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven links between the pain reliever and autism.
A federal report on Monday is expected to point to the active ingredient in painkillers like Tylenol. But research into a possible connection has yielded mixed results.
Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to produce the treatment for more patients.
The fallout of the war in Sudan has led to one of the world’s worst humanitarian crises, but aid to its victims is vanishing. Pregnant women’s lives are in the balance.